Response of dystrophic calcification to intravenous immunoglobulin

Archives of Dermatology

Volumn 144, Issue 5, 2008, Pages 585-587

  Schanz, Stefan ^a   Ulmer, Anja ^a   Fierlbeck, Gerhard ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN; PENICILLAMINE; SCL 70 ANTIBODY; WARFARIN;

ADULT; ARTICLE; CALCINOSIS; CASE REPORT; ESOPHAGUS DISEASE; FEMALE; HUMAN; LUNG FIBROSIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLEROSIS; SEROLOGY; SPIROMETRY; SYNDROME CREST; WOUND HEALING;

CALCINOSIS; CREST SYNDROME; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EDEMA; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFLAMMATION; MIDDLE AGED; TREATMENT OUTCOME;

EID: 44249115801     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.5.585     Document Type: Article

References (17)

1. Boulman N, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in rheumatic diseases. Semin Arthritis Rheum. 2005;34(6):805-812.
2. Dutz J. Treatment options for localized scleroderma. Skin Therapy Lett. 2000;5(2):3-5.
3. Bottomley WW, Goodfield MJ, Sheehan-Dare RA. Digital calcification in systemic sclerosis: effective treatment with good tissue preservation using the carbon dioxide laser. Br J Dermatol. 1996;135(2):302-304.
4. Sparsa A, Lesaux N, Kessler E, et al. Treatment of cutaneous calcinosis in CREST syndrome by extracorporeal shock wave lithotripsy. J Am Acad Dermatol. 2005;53(5)(suppl 1):S263-S265.
5. Cherin P, Herson S, Wechsler B, et al. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med. 1991;91(2):162-168.
6. Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med. 1993;329(27):1993-2000.
7. Levy Y, Amital H, Langevitz P, et al. Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. Arthritis Rheum. 2004;50(3):1005-1007.
8. Clements PJ, Lachenbruch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol. 1993;20(11):1892-1896.
9. Berger RG, Featherstone GL, Raasch RH, McCartney WH, Hadler NM. Treatment of calcinosis universalis with low-dose warfarin. Am J Med. 1987;83(1):72-76.
10. Moore SE, Jump AA, Smiley JD. Effect of warfarin sodium therapy on excretion of 4-carboxy-L-glutamic acid in scleroderma, dermatomyositis, and myositis ossificans progressiva. Arthritis Rheum. 1986;29(3):344-351.
11. Mukamel M, Horev G, Mimouni M. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr. 2001;138(5):763-766.
12. Clynes R. IVIG therapy: interfering with interferon-gamma. Immunity. 2007;26(1):4-6.
13. Ballow M. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases. J Allergy Clin Immunol. 1997;100(2):151-157.
14. Siragam V, Crow AR, Brinc D, Song S, Freedman J, Lazarus AH. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nat Med. 2006;12(6):688-692.
15. Bruhns P, Samuelsson A, Pollard JW, Ravetch JV. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity. 2003;18(4):573-581.
16. Park-Min KH, Serbina NV, Yang W, et al. FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin. Immunity. 2007;26(1):67-78.
17. Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006;313(5787):670-673.